Understand the source comparison
Synthetic Production vs Glandular Extract: What Changes and What Doesn't
Solid-phase peptide synthesis (SPPS) builds EDR by sequentially coupling protected amino acids to a resin-bound growing chain. Glutamic acid first, then aspartic acid, then arginine. Each coupling cycle uses activating agents like HBTU or DIC to form the pepti
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Solid-phase peptide synthesis (SPPS) builds EDR by sequentially coupling protected amino acids to a resin-bound growing chain. Glutamic acid first, then aspartic acid, then arginine. Each coupling cycle uses activating agents like HBTU or DIC to form the peptide bond, followed by deprotection to expose the next reactive site. Once assembly is complete, the peptide is cleaved from the resin, purified via reversed-phase HPLC to remove truncated sequences and side products, then lyophilised into powder form. The result is a defined molecular entity with verified mass spectrometry confirmation and purity typically exceeding 98%.
- Pinealon extract originates from bovine pineal glands. Freeze-dried tissue is homogenised, enzymatically digested to break down cellular structures, then filtered and chromatographed to isolate low-molecular-weight peptides. The final extract contains EDR alongside other pineal peptides (epithalon's tetrapeptide sequence AEDG is often co-present), melatonin precursors, and residual lipids. Published assays show EDR represents 60–75% of the peptide content in high-quality Pinealon batches, but concentration variability of ±15% between production runs is documented.
- The neuroprotective effect does not differ when EDR concentration is normalised. Administering 1mg of pure synthetic EDR produces the same BDNF upregulation and ChAT activity as administering 1.3–1.5mg of Pinealon extract (adjusted for 70% EDR content). What synthetic production eliminates is the immune response risk from residual glandular proteins and the regulatory complexity of using animal-derived materials in jurisdictions with TSE (transmissible spongiform encephalopathy) restrictions.
- Our experience working with peptide suppliers across research institutions shows that batch consistency matters more than origin when reproducibility is the goal. Pinealon extracts sourced from Real Peptides' full peptide collection undergo third-party HPLC verification, but synthetic EDR removes one layer of variability entirely.